Raposo, Nicolas http://orcid.org/0000-0002-9152-4445
Planton, Mélanie
Payoux, Pierre
Péran, Patrice
Albucher, Jean François
Calviere, Lionel
Viguier, Alain
Rousseau, Vanessa
Hitzel, Anne
Chollet, François
Olivot, Jean Marc
Bonneville, Fabrice
Pariente, Jérémie
Article History
Received: 3 May 2019
Accepted: 16 July 2019
First Online: 29 July 2019
Compliance with ethical standards
:
: Dr. Payoux reports personal fees from Lilly/Avid and from GE Heathcare. Dr. Albucher received consulting fees from Bayer and speaker honoraria from Boehringer Ingelheim, Bayer, and Pfizer. Dr. Calviere received consulting fees from Boehringer Ingelheim and travel grant from Boehringer Ingelheim and Pfizer. Dr. Chollet served as a consultant for Institut de Recherche Pierre Fabre and has received speaker honoraria from Bristol-Myers Squibb and Boston Scientific. Dr. Olivot received consulting fees from AstraZeneca, Servier, and Boston Scientific and speaker honoraria from Boehringer Ingelheim, Pfizer, and Bristol-Myers Squibb. Dr. Pariente is an associate editor of the Journal of Alzheimer’s Disease and has received speaker honoraria from Lilly, Roche, and Novartis. All other authors declare that they have no conflict of interest.
: The funders had no role in the design or conduct of the study; in the collection, management, analysis, or interpretation of the data; in the preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Toulouse-Purpan Hospital Ethical Standards Committee on Human Experimentation; No. 1122302) and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from each participant (or a legally authorized representative) included in the study.